Direct acting sympathomimetics – Xylometazoline MCQs With Answer
Direct acting sympathomimetics such as xylometazoline are important nasal decongestants widely covered in B. Pharm pharmacology and therapeutics. This introduction explains key concepts: mechanism of action as an alpha-adrenergic agonist, topical formulation benefits, pharmacokinetics, dosing, adverse effects including rhinitis medicamentosa, contraindications, and drug interactions. Understanding receptor selectivity, onset and duration, systemic absorption risks, and differences from other agents (oxymetazoline, phenylephrine) is essential for safe dispensing and counselling. These focused MCQs reinforce clinical and mechanistic knowledge required for examinations and practice. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which receptor subtype is primarily activated by xylometazoline to produce nasal vasoconstriction?
- Beta-2 adrenergic receptor
- Alpha-1 adrenergic receptor
- Dopamine D2 receptor
- Muscarinic M3 receptor
Correct Answer: Alpha-1 adrenergic receptor
Q2. Xylometazoline is classified pharmacologically as which of the following?
- Indirect sympathomimetic
- Direct acting sympathomimetic
- Cholinergic agonist
- Anticholinergic agent
Correct Answer: Direct acting sympathomimetic
Q3. The primary therapeutic use of xylometazoline is:
- Bronchodilation in asthma
- Nasal decongestion in rhinitis
- Lowering intraocular pressure
- Treatment of hypertension
Correct Answer: Nasal decongestion in rhinitis
Q4. Which route of administration is most common for xylometazoline?
- Oral tablets
- Intravenous injection
- Topical intranasal spray or drops
- Transdermal patch
Correct Answer: Topical intranasal spray or drops
Q5. Xylometazoline produces vasoconstriction primarily by:
- Increasing cyclic AMP in vascular smooth muscle
- Stimulating alpha-adrenergic receptors leading to increased intracellular calcium
- Blocking histamine H1 receptors
- Inhibiting acetylcholine release
Correct Answer: Stimulating alpha-adrenergic receptors leading to increased intracellular calcium
Q6. A common adverse effect associated with prolonged topical use of xylometazoline is:
- Rhinitis medicamentosa (rebound congestion)
- Systemic hypotension
- Severe diarrhea
- Hepatotoxicity
Correct Answer: Rhinitis medicamentosa (rebound congestion)
Q7. Which factor increases the risk of systemic absorption of topical xylometazoline?
- Using the correct recommended dose only twice daily
- Damaged or inflamed nasal mucosa
- Using in combination with saline rinses
- Short duration therapy under 3 days
Correct Answer: Damaged or inflamed nasal mucosa
Q8. Compared with phenylephrine, xylometazoline typically has:
- Shorter duration of action
- Longer duration of action
- Only antihistaminic effects
- Stronger beta-adrenergic activity
Correct Answer: Longer duration of action
Q9. The mechanism of rhinitis medicamentosa from xylometazoline involves:
- Downregulation of alpha receptors and tachyphylaxis
- Accumulation of histamine at receptor sites
- Permanent destruction of nasal cartilage
- Enhanced parasympathetic innervation
Correct Answer: Downregulation of alpha receptors and tachyphylaxis
Q10. Which population should use xylometazoline with caution due to potential cardiovascular effects?
- Patients with controlled asthma
- Patients with hypertension or coronary artery disease
- Young healthy adults
- Patients with localized nasal fungal infection
Correct Answer: Patients with hypertension or coronary artery disease
Q11. The onset of action for intranasal xylometazoline is typically:
- Within seconds to 5 minutes
- 30 to 60 minutes
- 2 to 4 hours
- One day
Correct Answer: Within seconds to 5 minutes
Q12. Which statement about pharmacokinetics of topical xylometazoline is correct?
- It is extensively metabolized in the liver after topical use with minimal systemic exposure under normal conditions
- Topical use always results in high systemic bioavailability
- It is excreted unchanged in large quantities in urine after topical use
- It crosses the blood-brain barrier and causes sedation at therapeutic topical doses
Correct Answer: It is extensively metabolized in the liver after topical use with minimal systemic exposure under normal conditions
Q13. Which enzyme system is most likely involved in the hepatic metabolism of small phenylmethylamines like xylometazoline?
- CYP450 mixed-function oxidases
- Monoamine oxidase exclusively
- Alcohol dehydrogenase only
- Glutathione-S-transferase only
Correct Answer: CYP450 mixed-function oxidases
Q14. In overdose of xylometazoline, which symptom is least likely?
- Severe hypertension
- Reflex bradycardia
- Confusion or CNS stimulation
- Profound hypoglycemia
Correct Answer: Profound hypoglycemia
Q15. Which drug interaction is most relevant when a patient using xylometazoline is also taking a monoamine oxidase inhibitor (MAOI)?
- Risk of severe hypotension
- Risk of exaggerated hypertensive response
- No interaction because xylometazoline is topical
- Decreased efficacy of xylometazoline
Correct Answer: Risk of exaggerated hypertensive response
Q16. Xylometazoline’s chemical action is best described as:
- Releasing stored norepinephrine from nerve terminals
- Direct agonism at adrenergic receptors
- Inhibition of catecholamine synthesis
- Blocking reuptake of serotonin
Correct Answer: Direct agonism at adrenergic receptors
Q17. Which adverse effect is commonly reported with topical xylometazoline use?
- Nasal dryness and irritation
- Severe liver enzyme elevation
- Renal failure
- Complete loss of smell permanently
Correct Answer: Nasal dryness and irritation
Q18. For adults, recommended short-term intranasal dosing frequency of xylometazoline is typically:
- Every 2–3 hours indefinitely
- Once daily only at bedtime
- Every 8–10 hours, not exceeding recommended duration
- Continuous nebulization
Correct Answer: Every 8–10 hours, not exceeding recommended duration
Q19. Duration of action for xylometazoline is approximately:
- 30 minutes
- 4–10 hours
- 24–48 hours
- Less than 5 minutes
Correct Answer: 4–10 hours
Q20. Structural features that promote alpha-adrenergic activity in xylometazoline include:
- Large polar carbohydrate moiety
- Aromatic ring with alkyl substitution and imidazoline-like structure
- Peptide backbone
- Sulfonamide group
Correct Answer: Aromatic ring with alkyl substitution and imidazoline-like structure
Q21. In terms of receptor selectivity, xylometazoline preferentially stimulates:
- Beta-1 receptors in the heart
- Alpha-1 and some alpha-2 receptors in nasal vessels
- Histamine H2 receptors in stomach
- GABA receptors in the CNS
Correct Answer: Alpha-1 and some alpha-2 receptors in nasal vessels
Q22. Which contraindication is most appropriate for xylometazoline use?
- Local bacterial sinusitis without nasal congestion
- Severe uncontrolled hypertension
- Mild seasonal allergic rhinitis in adults
- Intermittent use for acute congestion
Correct Answer: Severe uncontrolled hypertension
Q23. The term tachyphylaxis in the context of xylometazoline refers to:
- Increased drug effect with repeated dosing
- Rapid decrease in response after repeated use
- Allergic reaction after first dose
- Slow onset of action over days
Correct Answer: Rapid decrease in response after repeated use
Q24. Which clinical counseling point is important for patients using xylometazoline?
- Use continuously for months for best effect
- Limit use to recommended duration (usually ≤7 days) to avoid rebound congestion
- Swallow the spray for systemic effect
- Combine with oral MAOI for better nasal relief
Correct Answer: Limit use to recommended duration (usually ≤7 days) to avoid rebound congestion
Q25. When comparing xylometazoline and oxymetazoline, which is true?
- Both are topical alpha agonists with long duration suitable for nasal decongestion
- Oxymetazoline is an antimuscarinic while xylometazoline is an H1 blocker
- Xylometazoline is oral while oxymetazoline is topical
- They act primarily as beta-2 agonists for bronchodilation
Correct Answer: Both are topical alpha agonists with long duration suitable for nasal decongestion
Q26. Which laboratory monitoring is routinely required for short-term topical xylometazoline use?
- Frequent liver function tests
- No routine laboratory monitoring is required
- Daily serum catecholamine levels
- Coagulation profile every week
Correct Answer: No routine laboratory monitoring is required
Q27. Pediatric use of xylometazoline requires caution because:
- Children are less responsive and need higher doses
- Risk of systemic side effects and dosing errors in infants
- It is the preferred syrup formulation for infants
- There is no risk; it is safe for continuous use
Correct Answer: Risk of systemic side effects and dosing errors in infants
Q28. Which symptom would most suggest systemic absorption of xylometazoline?
- Local rhinorrhea only
- Tachycardia, hypertension, or headache
- Improved taste sensation
- Increased tear production only
Correct Answer: Tachycardia, hypertension, or headache
Q29. Mechanistically, alpha-2 receptor stimulation in nasal mucosa by drugs like xylometazoline may:
- Increase mucus production dramatically
- Reduce sympathetic tone systemically
- Contribute to vasoconstriction and decreased nasal blood flow
- Activate histamine release from mast cells
Correct Answer: Contribute to vasoconstriction and decreased nasal blood flow
Q30. Which formulation change reduces systemic absorption of topical sympathomimetics?
- Addition of preservatives that increase mucosal permeability
- Use of lower concentration or single-dose spray formulations
- Increasing lipophilicity drastically
- Formulation into a mucosal solvent
Correct Answer: Use of lower concentration or single-dose spray formulations
Q31. In patients with diabetes, xylometazoline should be used with caution because:
- It directly causes severe hyperglycemia
- Sympathomimetics may affect cardiovascular status and glucose control indirectly
- It cures diabetic neuropathy
- It acts as an insulin secretagogue
Correct Answer: Sympathomimetics may affect cardiovascular status and glucose control indirectly
Q32. What is the recommended action when rhinitis medicamentosa develops from xylometazoline?
- Increase the dose for better effect
- Gradual withdrawal or switch to topical corticosteroid and saline therapy
- Start oral antibiotics immediately
- Continue indefinitely to prevent congestion
Correct Answer: Gradual withdrawal or switch to topical corticosteroid and saline therapy
Q33. Xylometazoline is pregnancy category recommendation generally:
- Considered absolutely contraindicated in all trimesters
- Use with caution; topical use may be considered if benefits outweigh risks
- Recommended as first-line oral decongestant in pregnancy
- Proven teratogen and banned in pregnancy
Correct Answer: Use with caution; topical use may be considered if benefits outweigh risks
Q34. Which sign indicates acute overdose of intranasal xylometazoline in a child?
- Excessive salivation only
- Restlessness, hypertension, tachycardia or CNS depression
- Immediate improvement without side effects
- Profound hypothermia only
Correct Answer: Restlessness, hypertension, tachycardia or CNS depression
Q35. Which property explains prolonged local effect of xylometazoline compared to some other decongestants?
- High systemic clearance but rapid local metabolism
- High lipophilicity and sustained local receptor binding
- Complete systemic absorption and storage in fat
- Rapid enzymatic degradation at mucosa
Correct Answer: High lipophilicity and sustained local receptor binding
Q36. A pharmacist counsels a patient that maximum recommended duration of OTC xylometazoline use is typically:
- 3–5 days
- Indefinite as long as symptoms persist
- At least 6 months continuous use
- Once weekly for maintenance
Correct Answer: 3–5 days
Q37. Which is an appropriate method to minimize rebound congestion when stopping chronic xylometazoline?
- Immediate abrupt discontinuation always without alternatives
- Switch to saline nasal sprays and consider topical nasal corticosteroids during withdrawal
- Replace with oral sympathomimetic at higher doses
- Increase dose for two weeks then stop
Correct Answer: Switch to saline nasal sprays and consider topical nasal corticosteroids during withdrawal
Q38. Which systemic condition could be exacerbated by systemic absorption of xylometazoline?
- Hypotension and bradycardia
- Ischemic heart disease due to vasoconstriction
- Improved peripheral perfusion
- Severe hyperkalemia
Correct Answer: Ischemic heart disease due to vasoconstriction
Q39. In terms of teaching B. Pharm students about drug interactions, xylometazoline combined with systemic sympathomimetics may cause:
- Reduced blood pressure due to antagonism
- Excessive vasoconstriction and hypertension
- Complete neutralization of effect
- Immediate renal clearance enhancement
Correct Answer: Excessive vasoconstriction and hypertension
Q40. Which formulation excipient can cause local irritation in some xylometazoline nasal sprays?
- Isotonic saline only
- Preservatives such as benzalkonium chloride
- Pure water without preservatives
- Glycerin exclusively
Correct Answer: Preservatives such as benzalkonium chloride
Q41. Which pharmacological class best describes drugs used to manage rhinitis medicamentosa rebound congestion?
- Topical alpha agonists with longer duration
- Topical nasal corticosteroids and saline irrigations
- Systemic beta blockers
- Oral antifungals
Correct Answer: Topical nasal corticosteroids and saline irrigations
Q42. Which is true about systemic side effects of topical xylometazoline in elderly patients?
- Elderly are less sensitive to sympathomimetics and never show side effects
- They may have increased sensitivity and higher risk of cardiovascular events
- Topical use causes only local allergic reactions in elderly
- Elderly always require double the dose for efficacy
Correct Answer: They may have increased sensitivity and higher risk of cardiovascular events
Q43. Which monitoring is advisable for patients with severe cardiovascular disease using topical xylometazoline?
- No monitoring required; totally safe
- Monitor blood pressure and heart rate and avoid prolonged use
- Weekly liver biopsy
- Continuous EEG monitoring
Correct Answer: Monitor blood pressure and heart rate and avoid prolonged use
Q44. The concept of selectivity in xylometazoline pharmacology means:
- It activates only one neurotransmitter system exclusively
- It preferentially stimulates certain adrenergic receptor subtypes at therapeutic doses
- It blocks all adrenergic receptors equally
- It is selective for cholinergic receptors
Correct Answer: It preferentially stimulates certain adrenergic receptor subtypes at therapeutic doses
Q45. Which exam-relevant point should B. Pharm students remember about administration technique?
- Patients should lie flat and administer large volumes quickly
- A gentle sniff after spray and avoiding excess use helps local effect and reduces systemic absorption
- Always instruct patients to swallow the spray
- Shake vigorously and ingest orally for better effect
Correct Answer: A gentle sniff after spray and avoiding excess use helps local effect and reduces systemic absorption
Q46. Which statement about chronic nasal decongestant overuse is accurate?
- Overuse can lead to chronic mucosal edema and dependency
- Overuse improves long-term nasal mucosal health
- There are no consequences to long-term continuous use
- Overuse prevents any future allergic rhinitis
Correct Answer: Overuse can lead to chronic mucosal edema and dependency
Q47. Which clinical scenario would contraindicate intranasal xylometazoline use?
- Acute allergic rhinitis with mild congestion
- Patient on MAOI presenting with nasal congestion
- Temporary nasal congestion from common cold for 2 days
- Short-term postoperative nasal swelling under physician supervision
Correct Answer: Patient on MAOI presenting with nasal congestion
Q48. Which teaching point is important regarding pediatric dosing labels for xylometazoline products?
- All pediatric sprays have the same concentration and dose
- Read product labels carefully; concentrations and age recommendations vary
- Pediatric dosing can be extrapolated from adult dose by halving it
- Homeopathic dosing is standardized across brands
Correct Answer: Read product labels carefully; concentrations and age recommendations vary
Q49. From a medicinal chemistry perspective, imidazoline derivatives like xylometazoline are designed to:
- Enhance cholinergic receptor binding
- Improve alpha-adrenergic receptor affinity and topical potency
- Act as broad-spectrum antibiotics
- Increase opioid receptor agonism
Correct Answer: Improve alpha-adrenergic receptor affinity and topical potency
Q50. Which statement best summarizes safe clinical use of xylometazoline for pharmacy practice?
- Advise indefinite use for symptom control without precautions
- Recommend short-term, lowest effective dose, counsel on rebound congestion and cardiovascular risks
- Advise combination with systemic sympathomimetics routinely
- Recommend use as first-line therapy for chronic nasal obstruction without physician input
Correct Answer: Recommend short-term, lowest effective dose, counsel on rebound congestion and cardiovascular risks
